Skip to content

A study to evaluate the effect of food ingredient in healthy adult on the immune system

A study to evaluate the effect of food ingredient in healthy adult on the immune system - A study to evaluate the effect of food ingredient in healthy adult on the immune system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042948
Enrollment
100
Registered
2022-04-25
Start date
2020-12-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Ingestion of test food(research food) Ingestion of placebo

Sponsors

TTC Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females from 20 to 64 years of age (2) Subjects who are aware that they are susceptible to colds (3) Subjects with a low QOL questionnaire score

Exclusion criteria

Exclusion criteria: (1) Subjects who regularly intake food containing involvement ingredients at least 3 times a week. (2) Subjects who constantly use supplements or drugs affecting the immune system. (3) Subjects who regularly intake food or medicines rich in lactic acid bacteria at least 3 times a week (4) Subjects with medicine or food allergy (5) Subjects who have oral or dental problems with bleeding or develops the trouble at least once a week (6) Subjects who are under medication which may influence the outcome of the study (e.g. specific desensitization therapy) (7) Night and day shift worker or manual laborer (8) Subjects who are habitually vigorous exercise such as marathon (include professional athlete) (9) Subjects who cannot carry out the inspection procedure of various inspection by the rule during the study period (10) Subjects are undergoing medical treatment or judged as require medical treatment (11) Subjects who have under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, or heart disease and disease to affect the adrenal cortical hormone secretion) (12) Subjects having possibilities for emerging allergy related to the study (13) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (14) Subjects who intend to become pregnant or lactating (15) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (16) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (17) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Immune function

Countries

Japan

Contacts

Public ContactMariko Oe

Kewpie Corporation R&D Division

mariko_oe@kewpie.co.jp03-5384-7759

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026